Granted Patent B2

US 11,139,060 · App. 17/147,453 · Granted Oct 5, 2021

Inventors: Steven Mason (Las Vegas, NV); Daniel Posnack (Fort Lauderdale, FL); Peter Arn (Roxbury, CT); Wendy Para (Las Vegas, NV); S. Adam Hacking (Nashua, NH); Micheal Mueller (Oil City, PA); Joe Guaneri (Merrick, NY); Jonathan Greene (Denver, CO)

Assignee: ROM TECHNOLOGIES, INC.

G16H20/30A63B22/0605G16H50/30G16H80/00A63B2022/0635

Abstract

Claims (59)

1. A computer-implemented system, comprising:

a treatment device configured to be manipulated by a user while the user is performing a treatment plan;

a patient interface comprising an output device configured to present telemedicine information associated with a telemedicine session; and

a computing device configured to:

receive treatment data pertaining to the user who uses the treatment device to perform the treatment plan, wherein the treatment data comprises at least one of characteristics of the user, measurement information pertaining to the user, characteristics of the treatment device, and at least one aspect of the treatment plan;

identify at least one enhanced component using the treatment data;

generate an enhanced environment using the at least one enhanced component and the treatment plan;

output at least one aspect of the enhanced environment to at least one of the patient interface and another interface, wherein the other interface is configured to communicate with the treatment device;

receive subsequent treatment data pertaining to the user; and

selectively modify at least one of the enhanced environment and at least one of the at least one aspect of the treatment plan and any other aspect of the treatment plan using the subsequent treatment data.

2. The computer-implemented system of claim 1 , wherein the computing device is further configured to control, while the user uses the treatment device and based on at least one of the enhanced environment, the modified at least one of the enhanced environment, and the at least one of the at least one aspect of the treatment plan and any other aspect of the treatment plan, the treatment device.

3. The computer-implemented system of claim 1 , wherein the computing device is further configured to output, while the user uses the treatment device during the telemedicine session, the enhanced environment to the at least one of the patient interface and the other interface.

4. The computer-implemented system of claim 1 , wherein the computing device is further configured to selectively modify, using the subsequent treatment data while the user uses the treatment device, the at least one of the enhanced environment and at least one of the at least one aspect of the treatment plan and any other aspect of the treatment plan.

5. The computer-implemented system of claim 1 , wherein the computing device is further configured to selectively modify, using the subsequent treatment data while the user uses the treatment device during a telemedicine session, the at least one of the enhanced environment and at least one of the at least one aspect of the treatment plan and any other aspect of the treatment plan.

6. The computer-implemented system of claim 1 , wherein the measurement information includes at least one of a vital sign of the user, a respiration rate of the user, a heartrate of the user, a temperature of the user, an eye dilation measurement, a metabolic marker, a biomarker, and a blood pressure of the user.

7. A method comprising:

receiving treatment data pertaining to a user who uses a treatment device to perform a treatment plan, wherein the treatment data comprises at least one of characteristics of the user, measurement information pertaining to the user, characteristics of the treatment device, and at least one aspect of the treatment plan;

identifying at least one enhanced component using the treatment data;

generating an enhanced environment using the at least one enhanced component and the treatment plan;

outputting at least one aspect of the enhanced environment to an interface configured to communicate with the treatment device;

receiving subsequent treatment data pertaining to the user; and

selectively modifying, using the subsequent treatment data, at least one of the enhanced environment and at least one of the at least one aspect of the treatment plan and any other aspect of the treatment plan.

8. The method of claim 7 , further comprising controlling, while the user uses the treatment device and based on at least one of the enhanced environment, the modified at least one of the enhanced environment, and the at least one of the at least one aspect of the treatment plan and any other aspect of the treatment plan, the treatment device.

9. The method of claim 7 , wherein outputting at least one aspect of the enhanced environment to the interface further includes outputting, while the user uses the treatment device, during a telemedicine session, the at least one aspect of the enhanced environment to the interface.

10. The method of claim 7 , wherein selectively modifying the at least one of the enhanced environment and at least one of the at least one aspect of the treatment plan and any other aspect of the treatment plan further includes, selectively modifying, using the subsequent treatment data while the user uses the treatment device, the at least one of the enhanced environment and at least one of the at least one aspect of the treatment plan and any other aspect of the treatment plan.

11. The method of claim 7 , wherein selectively modifying the at least one of the enhanced environment and at least one of the at least one aspect of the treatment plan and any other aspect of the treatment plan further includes selectively modifying, using the subsequent treatment data while the user uses the treatment device during a telemedicine session, the at least one of the enhanced environment and at least one of the at least one aspect of the treatment plan and any other aspect of the treatment plan.

12. The method of claim 7 , wherein the measurement information includes at least one of a vital sign of the user, a respiration rate of the user, a heartrate of the user, a temperature of the user, an eye dilation measurement, a metabolic marker, a biomarker, and a blood pressure of the user.

13. The method of claim 7 , wherein the interface includes at least one enhanced reality device configured to present to the user, while the user uses the treatment device and based on the outputted enhanced environment, the enhanced environment.

14. The method of claim 13 , wherein the at least one enhanced reality device includes one of an augmented reality device, a virtual reality device, a mixed reality device, and an immersive reality device.

15. A tangible, non-transitory computer-readable medium storing instructions that, when executed, cause a processing device to:

receive treatment data pertaining to a user who uses a treatment device to perform a treatment plan, wherein the treatment data comprises at least one of characteristics of the user, measurement information pertaining to the user, characteristics of the treatment device, and at least one aspect of the treatment plan;

identify at least one enhanced component using the treatment data;

generate an enhanced environment using the at least one enhanced component and the treatment plan;

output at least one aspect of the enhanced environment to an interface configured to communicate with the treatment device;

receive subsequent treatment data pertaining to the user; and

selectively modify at least one of the enhanced environment and at least one of the at least one aspect of the treatment plan and any other aspect of the treatment plan using the subsequent treatment data.

16. The computer-readable medium of claim 15 , wherein the processing device is further configured to control, while the user uses the treatment device and based on at least one of the enhanced environment, the modified at least one of the enhanced environment, and the at least one of the at least one aspect of the treatment plan and any other aspect of the treatment plan, the treatment device.

17. The computer-readable medium of claim 15 , wherein the processing device is further configured to, while the user uses the treatment device, during a telemedicine session, output the at least one aspect of the enhanced environment to the interface.

18. The computer-readable medium of claim 15 , wherein the processing device is further configured to selectively modify, using the subsequent treatment data while the user uses the treatment device, the at least one of the enhanced environment and at least one of the at least one aspect of the treatment plan and any other aspect of the treatment plan.

19. The computer-readable medium of claim 15 , wherein the processing device is further configured to selectively modify, using the subsequent treatment data while the user uses the treatment device during a telemedicine session, the at least one of the enhanced environment and at least one of the at least one aspect of the treatment plan and any other aspect of the treatment plan.

20. The computer-readable medium of claim 15 , wherein the measurement information includes at least one of a vital sign of the user, a respiration rate of the user, a heartrate of the user, a temperature of the user, an eye dilation measurement, a metabolic marker, a biomarker, and a blood pressure of the user.

21. The computer-readable medium of claim 15 , wherein the interface includes at least one enhanced reality device configured to present to the user, while the user uses the treatment device and based on the outputted enhanced environment, the enhanced environment.

22. The computer-readable medium of claim 21 , wherein the at least one enhanced reality device includes one of an augmented reality device, a virtual reality device, a mixed reality device, and an immersive reality device.

23. A system comprising:

a processing device; and

a memory including instructions that, when executed by the processing device, cause the processing device to:

receive treatment data pertaining to a user who uses a treatment device to perform a treatment plan, wherein the treatment data comprises at least one of characteristics of the user, measurement information pertaining to the user, characteristics of the treatment device, and at least one aspect of the treatment plan;

identify at least one enhanced component using the treatment data;

generate an enhanced environment using the at least one enhanced component and the treatment plan;

output at least one aspect of the enhanced environment to an interface configured to communicate with the treatment device;

receive subsequent treatment data pertaining to the user; and

selectively modify at least one of the enhanced environment and at least one of the at least one aspect of the treatment plan and any other aspect of the treatment plan using the subsequent treatment data.

24. The system of claim 23 , wherein the instructions further cause the processing device to control, while the user uses the treatment device and based on at least one of the enhanced environment, the modified at least one of the enhanced environment, and the at least one of the at least one aspect of the treatment plan and any other aspect of the treatment plan, the treatment device.

25. The system of claim 23 , wherein the instructions further cause the processing device to, while the user uses the treatment device, during a telemedicine session, output the at least one aspect of the enhanced environment to the interface.

26. The system of claim 23 , wherein the instructions further cause the processing device to selectively modify, using the subsequent treatment data while the user uses the treatment device, the at least one of the enhanced environment and at least one of the at least one aspect of the treatment plan and any other aspect of the treatment plan.

27. The system of claim 23 , wherein the instructions further cause the processing device to selectively modify, using the subsequent treatment data while the user uses the treatment device during a telemedicine session, the at least one of the enhanced environment and at least one of the at least one aspect of the treatment plan and any other aspect of the treatment plan.

28. The system of claim 23 , wherein the measurement information includes at least one of a vital sign of the user, a respiration rate of the user, a heartrate of the user, a temperature of the user, an eye dilation measurement, a metabolic marker, a biomarker, and a blood pressure of the user.

29. The system of claim 23 , wherein the interface includes at least one enhanced reality device configured to present to the user, while the user uses the treatment device and based on the outputted enhanced environment, the enhanced environment.

30. The system of claim 29 , wherein the at least one enhanced reality device includes one of an augmented reality device, a virtual reality device, a mixed reality device, and an immersive reality device.

Continuity (4)

Cited By (54)

US 12,186,623 US 12,191,018 US 12,191,021 US 12,217,865 US 12,220,201 US 12,220,202 US 12,224,052 US 12,226,670 US 12,226,671 US 12,230,381 US 12,230,382 US 12,230,383 US 12,246,222 US 12,249,410 US 12,283,356 US 12,285,654 US 12,301,663 US 12,324,961 US 12,327,623 US 12,340,884 US 12,343,180 US 12,347,543 US 12,347,558 US 12,357,195 US 12,380,984 US 12,380,985 US 12,390,689 US 12,402,804 US 12,402,805 US 12,420,143 US 12,420,145 US 12,424,319 US 12,427,376 US 12,469,587 US 12,478,837 US 12,495,987 US 12,515,104 US 12,539,446 US 12,548,656 US 12,555,667 US 12,558,593 US 12,558,594 US 12,562,243 US 12,562,271 US 12,589,279 US 12,605,613 US 12,616,529 US 12,658,301 US 12,658,302 US 12,661,554 US 12,670,978 US 12,708,814 US 12,718,923 US 12,718,927